Company: INSP
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001609550-25-000053
Chunk: 34

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 34
---
24,070 $23,314 Operating lease liabilities:Accrued expenses$2,274 $1,754 Operating lease liabilities, non-current portion30,302 30,039 Total operating lease liabilities$32,576 $31,793 As of September 30, 2025, the remaining lease terms were 9.7 years and the weighted average discount rate was 4.9%. The operating cash outflows from our operating leases were $0.9 million and $0.5 million for the three-month 

20

Table of ContentsInspire Medical Systems, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

periods ended September 30, 2025 and 2024, respectively, and $2.5 million and $0.9 million for the nine-month periods ended September 30, 2025 and 2024, respectively.

4. Employee Retirement Plan

We sponsor a defined contribution employee retirement plan covering all of our full-time employees. The plan allows eligible employees to defer a portion of their eligible compensation up to the maximum allowed by IRS Regulations. We make voluntary matching contributions of 50% of the first 6% of each participating employee's contribution, up to 3% of eligible earnings. Our match contributions are made to funds designated by the participant, none of which are based on Inspire common stock. Our matching contributions to the plan totaled $1.3 million and $1.1 million for the three months ended September 30, 2025 and 2024, respectively, and $4.6 million and $3.7 million for the nine months ended September 30, 2025 and 2024, respectively.

5. Stockholders' Equity

Share Repurchase ProgramIn August 2024, our Board of Directors authorized the repurchase of up to $150.0 million of our outstanding shares of common stock from time to time through open market transactions, privately negotiated transactions, tender offers, or other means (the “2024 share repurchase program”). We were not obligated to repurchase any specific number of shares and the program could be modified, suspended, or discontinued at any time. The share repurchase program was set to expire in August 2026, subject to the earlier termination or extension by the Board, in its sole discretion and without prior notice.In November 2024, we entered into an accelerated share repurchase agreement (